Carrageenan in Baby Formula: What Parents Need to Know

What is carrageenan and why is it in infant formula?

Carrageenan is a family of high-molecular-weight sulfated polysaccharides extracted from red edible seaweeds, primarily species of the genus Chondrus, Kappaphycus, and Gigartina. It has been used in food processing for decades as a thickener, stabilizer, and emulsifier — most commonly in dairy products, processed meats, and beverages.

In infant formula, carrageenan serves a specific technical purpose: it prevents the separation of fat and protein in ready-to-feed liquid formulas. Without a stabilizer, oil droplets in a liquid formula can coalesce and separate — an undesirable texture and a potential uniformity issue. Carrageenan forms a gel-like matrix at low concentrations that keeps the emulsion stable during storage. Powder formulas, which are reconstituted at the point of use, typically do not require carrageenan for this purpose.

The FDA authorizes carrageenan in infant formula under 21 CFR 172.620. For a detailed profile of this additive including its chemical properties and full regulatory history, see the Additive Facts carrageenan profile.

The critical distinction: food-grade carrageenan vs. poligeenan

Understanding the carrageenan safety debate requires understanding one distinction that is frequently obscured in popular media coverage: food-grade carrageenan (Type I) and poligeenan are not the same compound.

Food-grade carrageenan has a molecular weight generally above 100,000 daltons. It is poorly absorbed by the gut. Poligeenan — formerly known as degraded carrageenan — is produced by acid hydrolysis of carrageenan at elevated temperatures, producing fragments with molecular weights below 50,000 daltons. Poligeenan is not approved for use in food anywhere in the world. The animal studies that showed intestinal inflammation, ulceration, and tumor promotion used poligeenan, not food-grade carrageenan. Regulatory agencies — including the FDA and EFSA — have consistently based their safety assessments on this distinction.

What the regulatory agencies actually found

The FDA re-affirmed carrageenan's authorization for infant formula use in 2018 after reviewing a citizen petition filed by the Cornucopia Institute, which had argued for its removal. The FDA concluded that the available evidence did not demonstrate that food-grade carrageenan in infant formula posed a safety risk.

EFSA's Panel on Food Additives and Nutrient Sources concluded in its 2017 opinion that carrageenan (E407) and processed eucheuma seaweed (E407a) did not raise a safety concern at current dietary exposures across age groups. The 2018 re-evaluation reached the same conclusion.

However, EU legislation applies additional restriction for the youngest infants: Commission Regulation (EU) 2017/2470 does not permit carrageenan in formula for infants under 16 weeks of age. This is a precautionary measure, not a finding of demonstrated harm — but it reflects the EU's generally more conservative approach to additives in products for infants.

The 2014 USDA organic vote and what it means

In 2014, the USDA's National Organic Standards Board (NOSB) voted 8 to 7 to recommend removing carrageenan from the National List of allowed substances in organic products. This vote was significant as a policy signal but is frequently misrepresented.

First, the NOSB vote was a recommendation, not a rule. The USDA did not implement the recommendation at the time. Second, the debate at the NOSB was partly about ingredient sourcing and organic consistency, not solely about safety evidence. Third, a number of formula manufacturers — most notably Abbott, which removed carrageenan from Similac Advance non-GMO in 2012 — acted ahead of any regulatory requirement, citing consumer preferences.

The practical result is that organic-certified formulas are more likely to be carrageenan-free than conventional formulas. But “organic” does not automatically mean “carrageenan-free,” and non-organic formulas are not automatically unsafe because they contain it.

What the ongoing scientific debate is actually about

The regulatory consensus supports food-grade carrageenan at current exposures. But a smaller body of research — primarily from the laboratory of Dr. Joanne Tobacman at the University of Illinois Chicago — argues that food-grade carrageenan activates inflammatory pathways in intestinal cells even at concentrations achievable through normal dietary exposure, and that it may exacerbate gastrointestinal conditions.

EFSA reviewed this body of work in its 2018 re-evaluation and concluded the mechanistic evidence was not sufficient to revise its safety conclusion. Critics of EFSA's position argue that in vitro and animal data suggesting inflammatory effects warrant more caution, particularly for vulnerable populations like infants with developing gut microbiomes.

This is an active scientific disagreement — not a resolved one. The current regulatory position is that food-grade carrageenan is safe. Some researchers and consumer organizations dispute this. For more context on how similar debates play out, see our article on emulsifiers and gut health and for the broader caution-rated additive landscape, browse our full Caution-rated additives list.

Frequently asked questions